Antiviral treatment of Argentine hemorrhagic fever
- Autores
- Enria, Delia; Maiztegui, Julio I.
- Año de publicación
- 1994
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Fil: Enria, Delia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.
Fil: Maiztegui, Julio I. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.
Argentine hemorrhagic fever is a systemic viral disease caused by Junin virus, with a mortality of 15-30% in untreated individuals. Current specific therapy is highly effective in reducing mortality, and consists of the early administration of immune plasma in defined doses of specific neutralizing antibodies per kg of body weight. However, several reasons suggest the need to investigate alternative therapies. Ribavirin, a broad spectrum antiviral agent, is effective in the treatment of other viral hemorrhagic fevers, and the studies done with Junin virus infections to date indicate that this drug may also have a beneficial effect in Argentine hemorrhagic fever. - Fuente
- Antiviral Research 1994; 23(1):23-31.
- Materia
-
Fiebre Hemorrágica Americana
Argentina
Antivirales - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- Repositorio
- Institución
- Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
- OAI Identificador
- oai:sgc.anlis.gob.ar:123456789/1952
Ver los metadatos del registro completo
id |
SGCANLIS_9fb6633d1bb8b2647b3ae0e9b4534081 |
---|---|
oai_identifier_str |
oai:sgc.anlis.gob.ar:123456789/1952 |
network_acronym_str |
SGCANLIS |
repository_id_str |
a |
network_name_str |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN |
spelling |
Antiviral treatment of Argentine hemorrhagic feverEnria, DeliaMaiztegui, Julio I.Fiebre Hemorrágica AmericanaArgentinaAntiviralesFil: Enria, Delia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.Fil: Maiztegui, Julio I. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.Argentine hemorrhagic fever is a systemic viral disease caused by Junin virus, with a mortality of 15-30% in untreated individuals. Current specific therapy is highly effective in reducing mortality, and consists of the early administration of immune plasma in defined doses of specific neutralizing antibodies per kg of body weight. However, several reasons suggest the need to investigate alternative therapies. Ribavirin, a broad spectrum antiviral agent, is effective in the treatment of other viral hemorrhagic fevers, and the studies done with Junin virus infections to date indicate that this drug may also have a beneficial effect in Argentine hemorrhagic fever.Elsevier1994-01info:ar-repo/semantics/articuloinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdf0166-3542http://sgc.anlis.gob.ar/handle/123456789/195210.1016/0166-3542(94)90030-2Antiviral Research 1994; 23(1):23-31.reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁNinstname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"instacron:ANLISAntiviral researchenginfo:eu-repo/semantics/openAccess2025-09-29T14:30:33Zoai:sgc.anlis.gob.ar:123456789/1952Institucionalhttp://sgc.anlis.gob.ar/Organismo científico-tecnológicoNo correspondehttp://sgc.anlis.gob.ar/oai/biblioteca@anlis.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:a2025-09-29 14:30:33.55Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"false |
dc.title.none.fl_str_mv |
Antiviral treatment of Argentine hemorrhagic fever |
title |
Antiviral treatment of Argentine hemorrhagic fever |
spellingShingle |
Antiviral treatment of Argentine hemorrhagic fever Enria, Delia Fiebre Hemorrágica Americana Argentina Antivirales |
title_short |
Antiviral treatment of Argentine hemorrhagic fever |
title_full |
Antiviral treatment of Argentine hemorrhagic fever |
title_fullStr |
Antiviral treatment of Argentine hemorrhagic fever |
title_full_unstemmed |
Antiviral treatment of Argentine hemorrhagic fever |
title_sort |
Antiviral treatment of Argentine hemorrhagic fever |
dc.creator.none.fl_str_mv |
Enria, Delia Maiztegui, Julio I. |
author |
Enria, Delia |
author_facet |
Enria, Delia Maiztegui, Julio I. |
author_role |
author |
author2 |
Maiztegui, Julio I. |
author2_role |
author |
dc.subject.none.fl_str_mv |
Fiebre Hemorrágica Americana Argentina Antivirales |
topic |
Fiebre Hemorrágica Americana Argentina Antivirales |
dc.description.none.fl_txt_mv |
Fil: Enria, Delia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina. Fil: Maiztegui, Julio I. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina. Argentine hemorrhagic fever is a systemic viral disease caused by Junin virus, with a mortality of 15-30% in untreated individuals. Current specific therapy is highly effective in reducing mortality, and consists of the early administration of immune plasma in defined doses of specific neutralizing antibodies per kg of body weight. However, several reasons suggest the need to investigate alternative therapies. Ribavirin, a broad spectrum antiviral agent, is effective in the treatment of other viral hemorrhagic fevers, and the studies done with Junin virus infections to date indicate that this drug may also have a beneficial effect in Argentine hemorrhagic fever. |
description |
Fil: Enria, Delia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina. |
publishDate |
1994 |
dc.date.none.fl_str_mv |
1994-01 |
dc.type.none.fl_str_mv |
info:ar-repo/semantics/articulo info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
0166-3542 http://sgc.anlis.gob.ar/handle/123456789/1952 10.1016/0166-3542(94)90030-2 |
identifier_str_mv |
0166-3542 10.1016/0166-3542(94)90030-2 |
url |
http://sgc.anlis.gob.ar/handle/123456789/1952 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Antiviral research |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
Antiviral Research 1994; 23(1):23-31. reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁN instname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán" instacron:ANLIS |
reponame_str |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN |
collection |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN |
instname_str |
Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán" |
instacron_str |
ANLIS |
institution |
ANLIS |
repository.name.fl_str_mv |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán" |
repository.mail.fl_str_mv |
biblioteca@anlis.gov.ar |
_version_ |
1844621858006106112 |
score |
12.559606 |